2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92542°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
SKÄÄÁî, ¼±Çà ¼­¸í Ä·ÆäÀÎ ½Ç½Ã (2013-10-28)
LG ¿Ã·¹µå °¶·¯¸® TV·Î ÇÁ¸®¹Ì¾ö TV ½ÃÀå °ø·« (2020-12-06)
Çѱ¹¼Ò¼È¹Ìµð¾îÁøÈï¿ø, ºÀÆò ¸ÀÁý ¡®°íÇ⸷±¹¼ö¡¯ ¼±Á¤ (2013-07-21)
°£Æí ȸÀÇ½Ç °Ë»ö ¹× ¿¹¾à ¾Û ¡®È¸ÀǽǴåÄÄ¡¯ (2020-08-29)
SKÅÚ·¹ÄÞ, ¡®Ã¢´ö ARirang ¾Ü Ȩ¡¯ ¼­ºñ½º Ãâ½Ã (2020-08-29)
IBM, AI Ȱ¿ëÇÑ ¼îÇÎ ½ÃÁð ¸ÅÃâ Àü¸Á ¹ßÇ¥ (2019-12-01)
½Å±Ô ¹ß°ß ·£¼¶¿þ¾î »ùÇÃ, 48% Áõ°¡ (2019-04-10)
ƽÅå, 2019 ºÎ»ê±¹Á¦±¤°íÁ¦ Âü°¡ (2019-08-24)
ÁÖÀ¯¼Ò Ȱ¿ëÇÑ Àü±âÂ÷ ÃæÀüÀÎÇÁ¶ó ±¸Ãà (2020-10-05)
Mishima Debuts World¡¯s First Made-to-Order Carbon Fiber Lou... (2021-11-17)
°³±×¸ÇÀ» ¿ô±â´Â °³±×¸Ç ±èÅÂÈ£ (2013-10-15)
°Ç±¹´ë Àι®»ó´ãÄ¡À¯Àü°ø, 2019 ½ÇÆÐ¹Ú¶÷ȸ Âü°¡ (2019-09-30)
¿¬±â¡¤¸ðµ¨Çпø, °è¾àÇÏ°í ³ª¸é ȯ±Þ±Ý µ¹·Á¹Þ±â ¾î·Á¿ö (2013-05-07)
ÃÊ¿¬°á »çȸ¸¦ ¾î¶»°Ô ¼±µµÇÒ °ÍÀΰ¡ (2019-06-23)
µðÅ¥ºê¹éÈ­Á¡, Áß¼Ò±â¾÷ ÆÇ·Î°³Ã´ µ½´Â ¡®µ¿¹Ý¼ºÀå¹Ú¶÷ȸ¡¯ °³ÃÖ (2013-06-13)
»ï¼ºÀüÀÚ, ÀϺ» »þÇÁ¿Í ÁöºÐ ÅõÀÚ°è¾à ü°á (2013-03-06)
Velodyne Lidar Calls for Action to Improve Pedestrian Safety (2021-09-16)
ÇѰ¡À§ ¸ÂÀÌ Àå¾ÖÀÎ °¡Á¤ ¹úÃÊ´ëÇà, ²É¹Ù±¸´Ï ¹è¼Û (2020-09-10)
»ùÇ¥, 2019 ±¹°¡¿¬±¸°³¹ß ¿ì¼ö¼º°ú 100¼±¿¡ ¼±Á¤ (2019-10-12)
¡®¸ðÆ« ¾Æ½Ã¾Æ Çãºê¡¯ Ãâ¹ü (2022-03-08)
±âº¹¾ø´Â Áß°í °æÂ÷, Àα⠺ñ°áÀº (2013-05-31)
½ÅÀÏ, °èÀý °æ°è Çã¹® ¡®³Ã³­¹æ±â¡¯·Î Àαâ¸ôÀÌ (2019-07-05)
¹æ ±¸Çϱ⠾ÖÇø®ÄÉÀÌ¼Ç ¡®Á÷¹æ¡¯ (2014-02-27)
´ëÇлý 10¸í Áß 7¸í, ¡®Àû¼º ¸ø ã¾Æ¡¯ (2013-06-12)
KT, All-IPÀÇ ±¤°í¼Ó ³ë·¡´ë°á (2013-03-05)
       [ÀÌÀü][1]....[3534][3535][3536][3537][3538][3539][3540][3541][3542]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..